Virginia Devonshire

1.8k total citations
35 papers, 1.2k citations indexed

About

Virginia Devonshire is a scholar working on Pathology and Forensic Medicine, Rheumatology and Oncology. According to data from OpenAlex, Virginia Devonshire has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 10 papers in Rheumatology and 9 papers in Oncology. Recurrent topics in Virginia Devonshire's work include Multiple Sclerosis Research Studies (30 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (7 papers). Virginia Devonshire is often cited by papers focused on Multiple Sclerosis Research Studies (30 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (7 papers). Virginia Devonshire collaborates with scholars based in Canada, United States and Switzerland. Virginia Devonshire's co-authors include Helen Tremlett, Yinshan Zhao, Yinshan Zhao, Joyce Pauline Joseph, B. C. Kieseier, R. Macdonell, Elliot M. Frohman, Paulo Fontoura, Robert Hyde and Laurent Suchet and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neurology.

In The Last Decade

Virginia Devonshire

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Devonshire Canada 14 1.0k 311 306 262 123 35 1.2k
Katharine Harding United Kingdom 18 1.0k 1.0× 334 1.1× 242 0.8× 244 0.9× 250 2.0× 47 1.3k
Christina Caon United States 20 783 0.8× 381 1.2× 211 0.7× 220 0.8× 117 1.0× 36 1.0k
Leszek Stawiarz Sweden 18 740 0.7× 274 0.9× 266 0.9× 118 0.5× 122 1.0× 35 1.0k
Claire Hirst United Kingdom 15 900 0.9× 374 1.2× 267 0.9× 189 0.7× 238 1.9× 27 1.2k
Trevor Pickersgill United Kingdom 13 675 0.7× 230 0.7× 156 0.5× 134 0.5× 114 0.9× 26 835
Adriana Carrá Argentina 12 717 0.7× 320 1.0× 225 0.7× 146 0.6× 141 1.1× 25 822
D Goodkin United States 10 724 0.7× 221 0.7× 220 0.7× 201 0.8× 131 1.1× 12 1.0k
E. Verdun Italy 14 843 0.8× 437 1.4× 379 1.2× 259 1.0× 148 1.2× 25 1.1k
Gabriel Pardo United States 17 660 0.6× 207 0.7× 135 0.4× 140 0.5× 194 1.6× 62 975
Liliana Patrucco Argentina 17 687 0.7× 269 0.9× 207 0.7× 98 0.4× 145 1.2× 83 992

Countries citing papers authored by Virginia Devonshire

Since Specialization
Citations

This map shows the geographic impact of Virginia Devonshire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Devonshire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Devonshire more than expected).

Fields of papers citing papers by Virginia Devonshire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Devonshire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Devonshire. The network helps show where Virginia Devonshire may publish in the future.

Co-authorship network of co-authors of Virginia Devonshire

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Devonshire. A scholar is included among the top collaborators of Virginia Devonshire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Devonshire. Virginia Devonshire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uy, Christopher, et al.. (2026). A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient Cohort. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 1–9.
2.
Sadovnick, A. Dessa, Maria Criscuoli, Irene M. Yee, et al.. (2024). Cesarian sections in women with multiple sclerosis: A Canadian prospective pregnancy study. Multiple Sclerosis Journal - Experimental Translational and Clinical. 10(4). 3110648746–3110648746.
3.
Marrie, Ruth Ann, Virginia Devonshire, Draga Jichici, et al.. (2023). Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS. Frontiers in Neurology. 14. 1101521–1101521. 5 indexed citations
4.
Vavasour, Irene M., Cornelia Laule, Roger Tam, et al.. (2022). Myelin heterogeneity for assessing normal appearing white matter myelin damage in multiple sclerosis. Journal of Neuroimaging. 33(2). 227–234. 2 indexed citations
5.
Pasquarelli, Noemi, et al.. (2022). Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data. Multiple Sclerosis and Related Disorders. 62. 103792–103792. 5 indexed citations
6.
Morrow, Sarah A., et al.. (2022). Use of natalizumab in persons with multiple sclerosis: 2022 update. Multiple Sclerosis and Related Disorders. 65. 103995–103995. 41 indexed citations
7.
Marrie, Ruth Ann, Draga Jichici, Luanne M. Metz, et al.. (2022). Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers. Frontiers in Neurology. 13. 904757–904757. 17 indexed citations
8.
Vavasour, Irene M., Pierre Becquart, Guojun Zhao, et al.. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple Sclerosis and Related Disorders. 57. 103422–103422. 6 indexed citations
9.
Giacomini, Paul S., et al.. (2021). Videoconferencing and Multiple Sclerosis Management: Stopgap or Stay Tuned?. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49(3). 402–405. 1 indexed citations
10.
Becquart, Pierre, John Petkau, Anthony Traboulsee, et al.. (2021). Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis. Multiple Sclerosis and Related Disorders. 57. 103366–103366. 12 indexed citations
11.
Freedman, Mark S., Virginia Devonshire, Pierre Duquette, et al.. (2020). Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 47(4). 437–455. 72 indexed citations
12.
Oh, Jiwon, Anat Achiron, Elisabeth Gulowsen Celius, et al.. (2020). Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Multiple Sclerosis and Related Disorders. 43. 102146–102146. 20 indexed citations
13.
Taylor, Carolyn, Ai‐Lan Nguyen, Virginia Devonshire, et al.. (2019). Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing–Remitting Multiple Sclerosis Patients. Journal of Neuro-Ophthalmology. 40(1). 37–43. 10 indexed citations
14.
Woodhall, Mark, Virginia Devonshire, Robert Carruthers, et al.. (2019). Myelin oligodendrocyte glycoprotein antibody-associated disease in a multi-ethnic Canadian cohort. Multiple Sclerosis Journal. 25. 810–811. 1 indexed citations
15.
Devonshire, Virginia, Anthony Feinstein, & Patrick M. Moriarty. (2016). Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study. BMC Research Notes. 9(1). 148–148. 13 indexed citations
16.
Sayao, Ana‐Luiza, et al.. (2014). Health-related quality of life in patients with longstanding ‘benign multiple sclerosis’. Multiple Sclerosis and Related Disorders. 4(1). 31–38. 12 indexed citations
17.
Sayao, Ana‐Luiza, et al.. (2011). The psychosocial and cognitive impact of longstanding ‘benign’ multiple sclerosis. Multiple Sclerosis Journal. 17(11). 1375–1383. 22 indexed citations
18.
Devonshire, Virginia, Yves Lapierre, R. Macdonell, et al.. (2010). The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis. European Journal of Neurology. 18(1). 69–77. 282 indexed citations
19.
Tremlett, Helen, Yinshan Zhao, Joyce Pauline Joseph, & Virginia Devonshire. (2008). Relapses in multiple sclerosis are age- and time-dependent. Journal of Neurology Neurosurgery & Psychiatry. 79(12). 1368–1374. 178 indexed citations
20.
Yoshida, Eric M., et al.. (2004). Remission of Multiple Sclerosis Post-Liver Transplantation. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 31(4). 539–541. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026